6[2]Sawamura T,Kume N,Aoyama T,et al.An endothelial receptor for oxidized low density lipoprotein[J].Nature,1997,386:73-77.
7[4]Lopez-Guisa JM,Koelsch K,Collins S,et al.Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury[J].Am J Physiol Renal Physiol,2007,293:F575-585.
8[5]Mita S,Kobayashi N,Yoshida K,et al.Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats[J].J Hypertens,2005,23:87-96.
9[6]Kobayashi N,Honda T,Yoshida K,et al.Critical role of bradykinin-eNOS and oxidative stress-LOX-1 pathway in cardiovascular remodeling under chronic angiotensin-converting enzyme inhibition[J].Atherosclerosis,2006,187:92-100.
10[7]Hisaki R,Fujita H,Saito F,et al.Tempol attenuates the development of hypertensive renal injury in Dahl salt-sensitive rats[J].Am J Hypertens,2005,18:707-713.
2Li Y,Fu L,Gao Q. Valsartan alleviates atherosclerotic lesions in pulmonary arteries of rabbits via an endothelium-dependent mechanism[J].ACTA CARDIOLOGICA,2010,(01):23-29.
3Sozen A B,Kayacan M S,Tansel T. Drugs with blocking effects on the renin-angiotensin-aldosterone system do not improve endothelial dysfunction long-term in hypertensive patients[J].Journal of International Medical Research,2009,(04):996-1002.
4Cangiano E,Marchesini J,Campo G. ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cel s in patients with acute coronary syndromes[J].Am J Cardiovasc Drugs,2011,(03):189-198.
